U.S. Army Neuromusculoskeletal Injuries Research Funding Announcement
$40,000,000 Program Announcements (#PA's) / #Funding Opportunity Announcements (#FOA's) aren't released very often, but the U.S. Army has done just that by releasing the "Restoring Warfighters with #Neuromusculoskeletal Injuries #Research Award (RESTORE)" funding announcement through the...
--To be administered by the Congressionally Directed Medical Research Program (#CDMRP).
Certainly a lot of words and acronyms, but we have the important information you need to know right here:
--Pre-Application Submission Deadline: 9/3/2019, 5pm Eastern Time
--Full Application Invitations Released: October, 2019
--Full Application Submission Deadline: 12/16/2019, 11:59pm Eastern Time
--Peer Review: February, 2020
--Programmatic Review: March 2020
--Funding Notifications: March-April, 2020
Research/Funding Level 1
--New ideas that represent innovative approaches and have the potential to make an important contribution
--The anticipated total (direct and indirect) costs will not exceed $500,000
Research/Funding Level 2
--Advancement of laboratory discovery, population-based studies, or #clinical knowledge into clinical application and acceleration toward a clinical solution
--The anticipated total (direct and indirect) costs will not exceed $1.5M
Research/Funding Level 3
--#Clinicaltrial s with the potential to have a significant impact on Warfighters who have incurred neuromusculoskeletal injuries
--The anticipated total (direct and indirect) costs will not exceed $3M
Focus Areas (our emphasis):
--Objective support tools to enable providers to assess function and performance throughout treatment and predict long-term outcomes
--Optimization of Warfighter performance following limb trauma or loss. Examples include, but are not limited to, #prosthetics and #orthotic solutions (e.g., intuitive control and sensation, interface, interoperability, prescription, and training), as well as #regenerative #rehabilitation solutions addressing #peripheral nerves, #skeletal muscle, and/or bone. Technology development is allowed. Regenerative studies without a rehabilitative component are not responsive to this funding opportunity
If any of this overlaps with your areas of interest, email us at email@example.com and we'll be happy to talk with you about your approach, and overall application strategy.